#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2570	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2045	353.1	0	.	n	.	0	C207T	SNP	207	207	C	394	394	T	368	T,C	151,155	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2570	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2045	353.1	0	.	n	.	0	C451T	SNP	451	451	C	638	638	T	357	T,C	153,145	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2570	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2045	353.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1371	1371	C	394	C	323	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2570	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2045	353.1	0	HET	.	.	.	C1450T	.	1450	1450	C	1637	1637	C	378	C,T	228,90	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2570	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2045	353.1	0	HET	.	.	.	C83CTCGGGTG	.	83	83	C	270	270	C	399	CTCGGGTG,C	282,88	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2570	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2045	353.1	0	HET	.	.	.	T84TCGGGTGGCG,TCG	.	84	84	T	271	271	T	396	TCGGGTGGCG,TCG	271,92	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4196	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3910	319.7	0	.	n	.	0	T695C	SNP	695	695	T	1124	1124	C	322	C,A,T	261,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4196	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3910	319.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2400	2400	C	378	C	321	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4196	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3910	319.7	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3026	3026	T	330	T	281	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4196	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3910	319.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2474	2474	A	379	A,C	315,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	386	folP	855	855	100.0	folP.l15.c4.ctg.1	1843	62.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1216	1218	AGC	90;90;90	A;G;C	73;75;72	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1000	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3841	78.0	1	SNP	p	S91F	1	.	.	271	273	TTC	809	811	TTC	97;97;97	T;T;C,A	83;83;81,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1000	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3841	78.0	1	SNP	p	D95G	1	.	.	283	285	GGC	821	823	GGC	98;98;99	G;G,T;C	85;83,1;83	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1000	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3841	78.0	1	SNP	p	G95N	0	.	.	283	285	GGC	821	823	GGC	98;98;99	G;G,T;C	85;83,1;83	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	368	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1633	67.1	1	SNP	p	G45D	0	.	.	133	135	GGC	597	599	GGC	99;99;100	G;G;C	84;85;84	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	262	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1369	57.4	0	.	n	.	0	A197.	DEL	197	197	A	734	734	A	104	A	92	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	876	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3419	76.8	1	SNP	p	D86N	0	.	.	256	258	GAC	793	795	GAC	114;115;116	G;A;C	90;95;93	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	876	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3419	76.8	1	SNP	p	S87R	1	.	.	259	261	CGT	796	798	CGT	115;115;115	C;G;T	97;93;90	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	876	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3419	76.8	1	SNP	p	R87I	0	.	.	259	261	CGT	796	798	CGT	115;115;115	C;G;T	97;93;90	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	876	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3419	76.8	1	SNP	p	R87W	0	.	.	259	261	CGT	796	798	CGT	115;115;115	C;G;T	97;93;90	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	876	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3419	76.8	1	SNP	p	S88P	0	.	.	262	264	TCC	799	801	TCC	115;117;116	T;C;C	89;94;97	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	868	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2884	89.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1732	1734	GGC	114;111;111	G;G;C	100;97;98	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2927	79.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1485	1487	GCC	103;103;103	G;C;C,A	87;89;88,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2927	79.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1488	1490	ATG	103;103;103	A;T;G,C	89;85;86,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2927	79.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1500	1502	ACC	108;109;108	A,G;C,T;C,G	94,1;90,1;91,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2927	79.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1500	1502	ACC	108;109;108	A,G;C,T;C,G	94,1;90,1;91,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2927	79.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2001	2003	ACC	116;115;115	A;C;C	96;91;98	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2927	79.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2055	2057	GCG	123;122;122	G,C;C;G	102,1;101;102	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2927	79.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2055	2057	GCG	123;122;122	G,C;C;G	102,1;101;102	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2927	79.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2178	2180	GGT	109;109;109	G,A;G;T	93,2;95;96	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2927	79.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2187	2189	AGC	111;110;110	A;G,T;C	97;94,1;92	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2927	79.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2205	2207	CCG	108;108;108	C;C,G;G	80;93,1;90	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	958	ponA	2397	2397	100.0	ponA.l6.c17.ctg.1	3351	85.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1699	1701	CCG	98;99;99	C;C,A;G	77;78,1;78	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	546	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2291	71.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	801	801	C	78	C	67	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	542	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1564	98.1	0	.	p	.	0	R144Q	NONSYN	430	432	CGG	720	722	CAG	122;119;119	C;A;G	96;95;94	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	542	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1564	98.1	0	.	p	.	0	G210R	NONSYN	628	630	GGA	918	920	AGA	115;115;115	A;G;A	97;95;95	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	542	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1564	98.1	0	.	p	.	0	S217G	NONSYN	649	651	AGT	939	941	GGT	116;115;114	G;G;T	96;97;100	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	542	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1564	98.1	1	SNP	p	G120K	1	.	.	358	360	AAG	648	650	AAG	115;116;115	A;A;G	89;91;92	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	542	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1564	98.1	1	SNP	p	A121N	1	.	.	361	363	AAC	651	653	AAC	115;115;116	A;A;C	86;89;90	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	542	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1564	98.1	1	SNP	p	N121D	0	.	.	361	363	AAC	651	653	AAC	115;115;116	A;A;C	86;89;90	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1778	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5391	98.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	282	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1268	65.6	1	SNP	p	V57M	1	.	.	169	171	ATG	641	643	ATG	118;117;118	A;T;G	99;99;97	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
